{"mainPropery":{"diseaseId":8532,"diseaseName":"Attenuated familial adenomatous polyposis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8532/attenuated-familial-adenomatous-polyposis","synonyms":["Attenuated FAP","AFAP","Mild form of FAP","Attenuated familial polyposis coli","Attenuated adenomatous polyposis coli","AAPC"],"synonyms-with-source":[{"name":"Attenuated FAP"},{"name":"AFAP"},{"name":"Mild form of FAP"},{"name":"Attenuated familial polyposis coli"},{"name":"Attenuated adenomatous polyposis coli"},{"name":"AAPC"}],"identifiers":[{"identifierType":"OMIM","identifierId":"175100"},{"identifierType":"ORPHANET","identifierId":"220460"},{"identifierType":"UMLS","identifierId":"C2674616"}]},"diseaseCategories":[],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":121,"resourceName":"Fight Colorectal Cancer","abbreviation":"","address1":"134 West Park Central Square","address2":" Suite 210","address3":"","address4":"","address5":"","city":"Springfield","state":"MO","zip":"65806","country":"United States","phone":"+1-703-548-1225 (Office)","tty":"","tollFree":"1-877-427-1211 (Helpline)","fax":"","email":"Info@FightCRC.org","url":"https://fightcolorectalcancer.org/","freeText":""},{"resourceID":122,"resourceName":"Colon Cancer Alliance","abbreviation":"","address1":"1025 Vermont Ave, NW","address2":"Suite 1066","address3":"","address4":"","address5":"","city":"Washington","state":"DC","zip":"20005","country":"United States","phone":" +1-202-628-0123 (Office)","tty":"","tollFree":"(877) 422-2030 (Helpline)","fax":"","email":"","url":"https://www.ccalliance.org/","freeText":""},{"resourceID":3307,"resourceName":"Hereditary Colon Cancer Foundation","abbreviation":"","address1":"3519 NE 15th Avenue","address2":"Unit 518","address3":"","address4":"","address5":"","city":"Portland","state":"OR","zip":"97212","country":"United States","phone":"+1-334-740-8657","tty":"","tollFree":"","fax":"","email":"info@HCCTakesGuts.org","url":"https://www.hcctakesguts.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/175100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=attenuated%20familial%20adenomatous%20polyposis' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Attenuated familial adenomatous polyposis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?term=attenuated+familial+adenomatous+polyposis' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Attenuated familial adenomatous polyposis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/familial-adenomatous-polyposis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Attenuated familial adenomatous polyposis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/142/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/175377-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=220460' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1345/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:175100' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Attenuated familial adenomatous polyposis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Attenuated familial adenomatous polyposis:<br />\r\n<a href='https://dtrf.org/patient-registry/' target='_blank'>DTRF Desmoid Tumor Patient Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":5784,"questionText":"What is attenuated familial adenomatous polyposis?","answerText":"<strong>Attenuated familial adenomatous polyposis (AFAP)</strong> is an inherited condition that increases the chance to develop cancer of the large intestine (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19218.htm\" target=\"_blank\">colon</a>) and rectum. It is a milder form of classic <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/6408/FAP.aspx\" target=\"_blank\">familial adenomatous polyposis</a>&nbsp;(FAP) and is characterized by fewer <a href=\"http://www.nlm.nih.gov/medlineplus/colonicpolyps.html\" target=\"_blank\">colon polyps</a> (an average of 30) and a delay in the development of colon cancer (average age 50 to 55 years). Other signs and symptoms may include&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=45614\" target=\"_blank\">benign</a> or <a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=\"_blank\">malignant</a>&nbsp;tumors of the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002347.htm\" target=\"_blank\">duodenum</a> (a section of the small intestine) and, in rare cases, other symptoms of FAP. AFAP is caused by <a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/APC\" target=\"_blank\">APC</a> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. AFAP is generally managed with regular screening to detect if and when polyps develop.[7935]","dateModified":"2015-04-06T00:00:00"},"basicQuestions":[{"questionId":5785,"questionText":"How might attenuated familial adenomatous polyposis be treated?","answerText":"Attenuated familial adenomatous polyposis (AFAP) is generally managed with regular screening to detect if and when polyps develop.[4776] Screening by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003886.htm\" target=\"_blank\">colonoscopy</a> has been recommended for affected people starting at age 20 to 25 years. People with polyps may undergo polypectomy (removal of polyps) followed by continued screenings every one to three years, depending on the number of polyps.[7935] A prophylactic <a href=\"http://www.mayoclinic.com/health/colectomy/MY00141/METHOD=print\" target=\"_blank\">colectomy</a> (removal of all or part of the colon) may be considered in people with too many&nbsp;adenomas to remove or those who cannot undergo screening.[7940] About one third of people with AFAP have few enough colon polyps that screening with periodic polypectomy is sufficient.[7935] <br />\r\n<br />\r\nBecause individuals with AFAP can also develop <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002347.htm\" target=\"_blank\">duodenal</a> adenomas and other cancers, <a href=\"http://digestive.niddk.nih.gov/ddiseases/pubs/upperendoscopy/\" target=\"_blank\">upper endoscopy</a> is typically recommended starting at age 20 to 30 years and then every one to three years, depending on the number of polyps. There is currently no consensus on screening for tumors that occur outside of the colon, so it has been suggested that affected individuals are managed as if they have classic FAP.[7940] <br />\r\n<br />\r\nA number of drugs such as <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009526/\" target=\"_blank\">celecoxib</a> and <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0012258/\" target=\"_blank\">sulindac</a> reportedly have been successful at reducing the number and the size of polyps in affected people, but these drugs generally help to prevent further complications and are not considered adequate treatment.[4776]<br />\r\n<br />\r\nAdditional and more detailed information about the treatment and management of FAP, including AFAP, is available on eMedicine's Web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/175377-treatment\" target=\"_blank\">here</a>.","dateModified":"2014-11-28T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":4776,"authors":"Mohammad Wehbi","articleTitle":"Familial Adenomatous Polyposis","bookWebsiteJournalTitle":"eMedicine","date":"September 1, 2011","url":"http://emedicine.medscape.com/article/175377-overview","dateAccessed":"2011-12-16T00:00:00"},{"referenceId":7935,"authors":"Kory W Jasperson, MS and Randall W Burt, MD","articleTitle":"APC-Associated Polyposis Conditions","bookWebsiteJournalTitle":"GeneReviews","date":"March 27, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1345/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7940,"authors":"Peter A L Bonis, MD; Dennis J Ahnen, MD; Lisen Axell, MS, CGC","articleTitle":"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families","bookWebsiteJournalTitle":"UpToDate","date":"April 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":5426,"authors":"Jasperson KW, Burt RW","articleTitle":"APC-Associated Polyposis Conditions","bookWebsiteJournalTitle":"GeneReviews","date":"March 27, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1345/","dateAccessed":"2014-06-23T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[{"caseId":50887,"abbreviatedInquiry":"I had one colonoscopy with 24 adenomatous polyps and one polyp had cancer in it. I have since been diagnosed with attenuated familial adenomatous polyposis (AFAP). I am wondering when it is recommended to remove the colon.","caseQuestions":[{"questionId":8524,"questionText":"When is removal of the colon recommended for individuals with attenuated familial adenomatous polyposis?","answerText":"In general,&nbsp;<a href=\"http://www.mayoclinic.com/health/colectomy/MY00141/METHOD=print\" target=\"_blank\">colectomy</a> (removal of all or part of the colon) may be considered in individuals with attenuated familial adenomatous polyposis (AFAP) when the number of polyps is too many to remove during <a href=\"http://www.nlm.nih.gov/medlineplus/colonoscopy.html\" target=\"_blank\">colonoscopy</a>.<span style=\"font-size: 14.3999996185303px;\">[7935]</span>[7492] &nbsp;Management guidelines for AFAP also suggest that colectomy may be appropriate when 21 or more polyps are identified during one colonoscopy, if any polyp is greater than one centimeter in size, or if any polyp is found to contain <a href=\"http://www.cancer.gov/dictionary?CdrID=46476\" target=\"_blank\">cells</a> that appear cancerous. &nbsp;Colectomy may also be considered if an individual with AFAP cannot or will not undergo regular screening.[7492]<br />\r\n<br />\r\nThe decision to have a colectomy is a very personal one and should be discussed with a physician who is familiar with AFAP; any decision should be based on physical findings, genetic testing results, and personal considerations.[7492]","dateModified":"2015-04-06T21:45:00","references":[{"referenceId":7492,"authors":"National Comprehensive Cancer Network","articleTitle":"Genetic/Familial High-Risk Assessment: Colorectal","bookWebsiteJournalTitle":"NCCN Clinical Practice Guidelines in Oncology","date":"2014","volume":"","pages":"","url":"http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf","dateAccessed":"2015-04-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7935,"authors":"Kory W Jasperson, MS and Randall W Burt, MD","articleTitle":"APC-Associated Polyposis Conditions","bookWebsiteJournalTitle":"GeneReviews","date":"March 27, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1345/","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":33349,"abbreviatedInquiry":"What is the recommended follow up or management of AFAP after the colon has been removed? The small intestine is connected to the rectum. I have had polyps in the rectum and also in the stomach since the colon was removed. How often do I need to do follow up tests to make sure nothing is growing in there?","caseQuestions":[{"questionId":5785,"questionText":"How might attenuated familial adenomatous polyposis be treated?","answerText":"Attenuated familial adenomatous polyposis (AFAP) is generally managed with regular screening to detect if and when polyps develop.[4776] Screening by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003886.htm\" target=\"_blank\">colonoscopy</a> has been recommended for affected people starting at age 20 to 25 years. People with polyps may undergo polypectomy (removal of polyps) followed by continued screenings every one to three years, depending on the number of polyps.[7935] A prophylactic <a href=\"http://www.mayoclinic.com/health/colectomy/MY00141/METHOD=print\" target=\"_blank\">colectomy</a> (removal of all or part of the colon) may be considered in people with too many&nbsp;adenomas to remove or those who cannot undergo screening.[7940] About one third of people with AFAP have few enough colon polyps that screening with periodic polypectomy is sufficient.[7935] <br />\r\n<br />\r\nBecause individuals with AFAP can also develop <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002347.htm\" target=\"_blank\">duodenal</a> adenomas and other cancers, <a href=\"http://digestive.niddk.nih.gov/ddiseases/pubs/upperendoscopy/\" target=\"_blank\">upper endoscopy</a> is typically recommended starting at age 20 to 30 years and then every one to three years, depending on the number of polyps. There is currently no consensus on screening for tumors that occur outside of the colon, so it has been suggested that affected individuals are managed as if they have classic FAP.[7940] <br />\r\n<br />\r\nA number of drugs such as <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009526/\" target=\"_blank\">celecoxib</a> and <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0012258/\" target=\"_blank\">sulindac</a> reportedly have been successful at reducing the number and the size of polyps in affected people, but these drugs generally help to prevent further complications and are not considered adequate treatment.[4776]<br />\r\n<br />\r\nAdditional and more detailed information about the treatment and management of FAP, including AFAP, is available on eMedicine's Web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/175377-treatment\" target=\"_blank\">here</a>.","dateModified":"2014-11-28T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":4776,"authors":"Mohammad Wehbi","articleTitle":"Familial Adenomatous Polyposis","bookWebsiteJournalTitle":"eMedicine","date":"September 1, 2011","url":"http://emedicine.medscape.com/article/175377-overview","dateAccessed":"2011-12-16T00:00:00"},{"referenceId":7935,"authors":"Kory W Jasperson, MS and Randall W Burt, MD","articleTitle":"APC-Associated Polyposis Conditions","bookWebsiteJournalTitle":"GeneReviews","date":"March 27, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1345/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7940,"authors":"Peter A L Bonis, MD; Dennis J Ahnen, MD; Lisen Axell, MS, CGC","articleTitle":"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families","bookWebsiteJournalTitle":"UpToDate","date":"April 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5786,"questionText":"What is the recommended follow-up for attenuated familial adenomatous polyposis after the colon has been removed?","answerText":"There is limited literature available that is specific to attenuated familial adenomatous polyposis (AFAP). Therefore, many experts suggest that people with AFAP follow the same screening guidelines as those with classic <a href=\"http://rarediseases.info.nih.gov/gard/6408/familial-adenomatous-polyposis/resources/1\" target=\"_blank\">familial adenomatous polyposis (FAP)</a>, which may include:[7935]\r\n<ul>\r\n    <li>If <a href=\"http://www.childrenshospital.org/clinicalservices/Site2577/mainpageS2577P29.html\" target=\"_blank\">total colectomy with ileo-anal pull-through</a> was performed: routine screening of the ileal pouch every two years\r\n    </li>\r\n    <li>If subtotal colectomy (removal of part of the colon) was performed: screening of the remaining rectum every six to 12 months, depending on the number of polyps that develop. Cancer may still occur in the remaining rectum, but the risk is much lower.\r\n    </li>\r\n    <li>Annual physical examination with palpation of the thyroid with consideration of follow-up ultrasound examination and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003899.htm\" target=\"_blank\">fine-needle aspiration</a> if thyroid nodules are present</li>\r\n</ul>\r\nExtra colonic manifestations of FAP generally require affected people to follow a lifelong screening program for the diagnosis and treatment of <a href=\"http://rarediseases.info.nih.gov/gard/6264/desmoid-tumor/resources/1\" target=\"_blank\">desmoid tumors</a> and benign and malignant tumors of the duodenum (a section of the small intestine), stomach, bones, skin, and other tissues.[4777]<br />\r\n<br />\r\nAdditional and more detailed information about follow-up recommendations for individuals with FAP or AFAP, including post-surgery recommendations is available at the following links:<br />\r\n<ul>\r\n    <li><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK1345/#fap.Management\" target=\"_blank\">GeneReviews - APC-Associated Polyposis Conditions</a>\r\n    </li>\r\n    <li><a href=\"http://www.fascrs.org/physicians/education/core_subjects/2006/fap/\" target=\"_blank\">American Society for Colon and Rectal Surgeons - Familial Adenomatous Polyposis (FAP)</a>\r\n    </li>\r\n    <li>Elizabeth Half, Dani Bercovich, and Paul Rozen. <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772987/?tool=pubmed\" target=\"_blank\">Familial adenomatous polyposis</a>. Orphanet J Rare Dis. 2009; 4: 22.</li>\r\n</ul>","dateModified":"2014-11-28T00:00:00","references":[{"referenceId":4777,"authors":"David W Dietz","articleTitle":"Familial Adenomatous Polyposis (FAP)","bookWebsiteJournalTitle":"American Society of Colon and Rectal Surgeons","date":"2011","url":"http://www.fascrs.org/physicians/education/core_subjects/2006/fap/","dateAccessed":"2011-12-16T00:00:00"},{"referenceId":7935,"authors":"Kory W Jasperson, MS and Randall W Burt, MD","articleTitle":"APC-Associated Polyposis Conditions","bookWebsiteJournalTitle":"GeneReviews","date":"March 27, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1345/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13541,"phenoTypeName":"Adenomatous colonic polyposis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":963,"phenoTypeName":"Colorectal polyposis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8876,"phenoTypeName":"Colon cancer","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9944,"phenoTypeName":"Duodenal polyposis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10359,"phenoTypeName":"Multiple gastric polyps","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":108,"phenoTypeName":"Neoplasm of the stomach","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8910,"phenoTypeName":"Rectal polyposis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13931,"phenoTypeName":"Adenocarcinoma of the colon","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5838,"phenoTypeName":"Astrocytoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10149,"phenoTypeName":"Carious teeth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10542,"phenoTypeName":"Congenital hypertrophy of retinal pigment epithelium","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":965,"phenoTypeName":"Epidermoid cyst","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2758,"phenoTypeName":"Fibroadenoma of the breast","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2753,"phenoTypeName":"Fibroma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11134,"phenoTypeName":"Increased number of teeth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9599,"phenoTypeName":"Multiple renal cysts","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7732,"phenoTypeName":"Osteoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9075,"phenoTypeName":"Papilloma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6023,"phenoTypeName":"Thyroid adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12633,"phenoTypeName":"Unerupted tooth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10064,"phenoTypeName":"Uterine leiomyoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15585,"phenoTypeName":"Adrenocortical adenoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7731,"phenoTypeName":"Desmoid tumors","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":12115,"phenoTypeName":"Duodenal adenocarcinoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4295,"phenoTypeName":"Hepatoblastoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4296,"phenoTypeName":"Medulloblastoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4304,"phenoTypeName":"Papillary thyroid carcinoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":103,"phenoTypeName":"Adrenocortical carcinoma","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":4111,"phenoTypeName":"Carcinoma","percentRanges":"-"},{"phenoTypeId":10277,"phenoTypeName":"Hyperpigmentation of the skin","percentRanges":"-"},{"phenoTypeId":14243,"phenoTypeName":"Keloids","percentRanges":"-"},{"phenoTypeId":8292,"phenoTypeName":"Multiple lipomas","percentRanges":"-"},{"phenoTypeId":11132,"phenoTypeName":"Odontoma","percentRanges":"-"},{"phenoTypeId":83,"phenoTypeName":"Small intestine carcinoid","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Attenuated_familial_adenomatous_polyposis"}